People v. Klaus CA5

CourtCalifornia Court of Appeal
DecidedJanuary 21, 2016
DocketF068339
StatusUnpublished

This text of People v. Klaus CA5 (People v. Klaus CA5) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
People v. Klaus CA5, (Cal. Ct. App. 2016).

Opinion

Filed 1/21/16 P. v. Klaus CA5

NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIFTH APPELLATE DISTRICT

THE PEOPLE, F068339 Plaintiff and Respondent, (Super. Ct. No. BF137080A) v.

GARY WILLIAM KLAUS, OPINION Defendant and Appellant.

APPEAL from a judgment of the Superior Court of Kern County. Eric J. Bradshaw, Judge. William W. Lee, under appointment by the Court of Appeal, for Defendant and Appellant. Kamala D. Harris, Attorney General, Gerald A. Engler, Chief Assistant Attorney General, Michael P. Farrell, Assistant Attorney General, Michael A. Canzoneri and Barton Bowers, Deputy Attorneys General, for Plaintiff and Respondent. -ooOoo- INTRODUCTION In 2011, appellant Gary William Klaus was involved in a vehicular accident in Bakersfield, California. The other driver was seriously injured. Law enforcement arrested appellant on suspicion of driving under the influence of alcohol and a jury subsequently convicted him of causing bodily injury while driving under the influence (Veh. Code, § 23153, subd. (a); count 1), finding true that great bodily injury was inflicted (Pen. Code, § 12022.7), but finding not true that his blood alcohol content was .15 percent or more (Veh. Code, § 23578). The jury found appellant not guilty of driving with a blood alcohol content of .08 percent or greater (Veh. Code, § 23153, subd. (b); count 2), as well as not guilty of the lessor included offense of driving under the influence (Veh. Code, § 23152, subd. (b)). Appellant was sentenced to an aggregate term of four years four months in prison. On appeal, appellant raises two issues. First, he asserts that the trial court abused its discretion in denying his motion in limine to exclude evidence of certain field sobriety tests (FSTs) law enforcement had him perform following the accident. He maintains that the trial court failed in its “gatekeeping function” to exclude speculative or irrelevant expert opinion as set forth in Sargon Enterprises, Inc. v. University of Southern California (2012) 55 Cal.4th 747, 770 (Sargon). He contends the court allowed the officer to testify at trial without sufficient foundational evidence regarding the officer’s methodology used to determine intoxication. Second, following his conviction, appellant filed a motion for new trial, contending juror misconduct occurred. Appellant’s counsel sought an evidentiary hearing in conjunction with the motion, which the trial court denied. Appellant argues the trial court abused its discretion in denying his request for the evidentiary hearing. Appellant’s arguments are without merit. We affirm.

2. BACKGROUND I. Trial Facts. A. Prosecution’s case. In May 2011, appellant was involved in a vehicle accident in Bakersfield, California. The other driver, Vanessa De La Cruz, entered the intersection on a green light where appellant’s vehicle struck her vehicle. Law enforcement and medical personnel responded to the scene. De La Cruz suffered extensive injuries and was subsequently hospitalized for 26 days. An officer spoke with appellant at the accident scene while appellant was still in the driver’s seat of his vehicle. Appellant indicated he was okay and he declined medical aid. The officer noticed a faint odor of alcohol emitting from appellant’s breath and person. Appellant’s responses to the officer were slow. The officer asked appellant if he would exit his vehicle and perform a FST. Appellant declined because he was not wearing shoes. As a result, the officer performed a horizontal gaze nystagmus (HGN) eye test while appellant remained in his vehicle. The officer observed some indicators that appellant was potentially under the influence of alcohol. Appellant lacked “smooth pursuit” when his eyes followed stimulus, his pupils were unusually constricted given the lighting conditions, and his responses to questions were slow. The officer observed an empty prescription pill bottle for hydrocodone in appellant’s vehicle. Appellant denied taking any hydrocodone that day. Later that day, appellant informed another officer he had undergone gastric bypass surgery approximately three weeks before the accident. A short time after the accident, an officer used a preliminary alcohol screening device (PASD) at the accident scene on appellant, who blew into it. The PASD registered a .19 percent alcohol content. Appellant was transported to Kern Medical Center, where his blood sample was taken and later tested. Appellant’s blood sample

3. showed an alcohol concentration of .16 percent. No narcotic analgesic was detected in appellant’s blood sample. Appellant was transported to the police station where he underwent additional FSTs. The officer who conducted these tests detected the smell of alcohol on appellant’s breath. Based on appellant’s performance, the officer opined that appellant was under the influence of alcohol along with a narcotic analgesic, and he was too impaired to drive. B. Defense case. Three eyewitnesses to the accident testified that they individually spoke with appellant at the accident scene while he was still in his vehicle and before emergency personnel arrived. These witnesses did not detect an odor of alcohol from appellant, and appellant did not appear intoxicated. Jim Valentine, a Ph.D. in medicinal chemistry, is a retired professor of pharmacology. He examined appellant on the morning of his trial testimony. Valentine determined that appellant suffers from nystagmus (jerky eye movement) in his right eye, which is a rare condition. Appellant’s pupils are also unusually small. He explained that blood samples taken from individuals could become fermented if not properly preserved or stored. He expressed concern that a person who was significantly overweight and who had been recently involved in a vehicle accident was a poor candidate for the FSTs. Valentine testified about the various problems with the FSTs used in this case, noting a person could fail such tests for reasons other than intoxication. Janine Arvizu, a Ph.D. candidate in chemistry, is a quality-assurance consultant. She opined that the instrument used to test the blood samples from appellant was not set up to identify or quantify alcohol in a scientifically-valid manner. She also expressed concern about how appellant’s blood sample was collected and stored. The tube containing appellant’s blood sample was under-filled, which could have allowed microorganisms to contaminate it, generating additional alcohol in the sample. Arvizu also saw no documentation indicating appellant’s sample was appropriately refrigerated

4. between its collection and analysis. She testified that she could not give any reliability to the blood results taken from appellant. C. Rebuttal evidence. Dan DeFraga is a supervising criminalist at the Kern Regional Crime Laboratory. He opined that the testing methods utilized on appellant’s blood sample were scientifically valid. DISCUSSION

I. The Trial Court Did Not Abuse Its Discretion In Denying Appellant’s Motion In Limine. Appellant asserts that the trial court erred in denying his motion in limine to exclude evidence of his FSTs. A. Background. Appellant filed pretrial motions in limine, including a request to exclude all evidence regarding his FSTs. He contended the FSTs were inadmissible primarily pursuant to People v. Kelly (1976) 17 Cal.3d 24 (Kelly), Frye v. United States (D.C. Cir. 1923) 293 F. 1013 (Frye), and Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993) 509 U.S. 579.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Sargon Enterprises, Inc. v. University of Southern California
288 P.3d 1237 (California Supreme Court, 2012)
People v. Duenas
281 P.3d 887 (California Supreme Court, 2012)
People v. Jones
275 P.3d 496 (California Supreme Court, 2012)
People v. Cox
809 P.2d 351 (California Supreme Court, 1991)
People v. Kelly
549 P.2d 1240 (California Supreme Court, 1976)
People v. Hayes
989 P.2d 645 (California Supreme Court, 2000)
Cinnamon Square Shopping Center v. Meadowlark Enterprises
24 Cal. App. 4th 1837 (California Court of Appeal, 1994)
People v. Hedgecock
795 P.2d 1260 (California Supreme Court, 1990)
People v. Hutchinson
455 P.2d 132 (California Supreme Court, 1969)
People v. Dykes
209 P.3d 1 (California Supreme Court, 2009)
People v. Carmony
92 P.3d 369 (California Supreme Court, 2004)
People v. Doolin
198 P.3d 11 (California Supreme Court, 2009)
Frye v. United States
293 F. 1013 (D.C. Circuit, 1923)

Cite This Page — Counsel Stack

Bluebook (online)
People v. Klaus CA5, Counsel Stack Legal Research, https://law.counselstack.com/opinion/people-v-klaus-ca5-calctapp-2016.